Business Overview of IBEX 

IBEX Technologies Inc. is a publicly traded company listed on the TSX-Venture Exchange (IBT.V).

The Company operates principally through  IBEX Pharmaceuticals Inc.

HEPARINASE I for DIAGNOSTICS

so-13485-logo-90x176-br

Heparinase I rapidly and specifically neutralizes both unfractionated heparin as well as low molecular weight heparin, allowing baseline hemostasis to be monitored in the presence of these anticoagulants.

Heparinase I is incorporated into disposables from a number of leading diagnostic companies, and is in development for additional diagnostic uses. Heparinase I for diagnostics are produced according to ISO 13485 standards.
To learn more press the button below.

MEDICAL DEVICE COMPONENTS

lyophilizing for contract manufacturing

In addition to manufacturing enzymes, IBEX also fills and lyophilizes medical device components for major international diagnostic companies.

These device components are in combination with sophisticated instruments such as the TEG® 5000 Thrombelastograph® Hemostasis Analyzer system which provides comprehensive whole blood hemostasis testing that can help assess bleeding and thrombotic risks, and also monitor antithrombotic therapies.

CONTRACT MANUFACTURING

ibex-fermentor-contract-manufacturing

IBEX produces enzyme regents for the some of the largest international diagnostic company.

Our contract services are available for:

  • SEED BANK CREATIONS
  • FERMENTATION AND BIOTRANSFORMATION
  • PROTEIN PURIFICATION
  • PROTEIN FORMULATION
  • FILLING OF DEVICE COMPONENTS & SMALL CONTAINERS
  • LYOPHILIZATION

Reagents are produced according to ISO 13485.
To learn more press the button below.

GLYCOSAMINOGLYCAN
(GAG) ENZYMES

heparinase enzyme 500x334

IBEX has developed a proprietary expression for producing our glycosaminoglycan (GAG) enzymes in Flavobacterium heparinum.  This system allows for producing each enzyme separately from other enzymes thus achieving the highest purity using a well-defined proprietary purification scheme, minimizing the cross contamination of other glycosaminoglycan enzymes which can occur when enzymes are produced from the native strain of Flavobacterium heparinum (Pedobacter heparinus).

IBEX Pharmaceutical’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research.

IBEX Pharmaceutical provides important services to major in-vitro companies some of which are acknowledged below:

  • Seed Bank Creation
  • Fermentation and Biotransformation
  • Protein Purification
  • Protein Formulation
  • Filling of Device Components
  • Lyophilization
  • Seed Bank Creation
  • Fermentation and Biotransformation
  • Protein Purification
  • Protein Formulation
  • Filling of Device Components
  • Lyophilization

The IBEX Pharmaceutical’s Quality Management System is certified ISO 13485:2016.

fermentor-contract-manufacturing-600x500

Selected Diagnostic Partnerships

Business Overview
Business Overview
tem_265x100
Business Overview
siemens_logo-150×99